Biolase inc.

BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR. BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON …

Biolase inc. Things To Know About Biolase inc.

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and …May 24, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $26.00 , which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.

LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- Biolase Technology, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of …Jul 28, 2022 · LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ... 14 sept 2014 ... Biolase develops, manufactures and markets laser systems that are used in dental procedures. Above, Biolase's flagship product, the Waterlase ...

The industry leading webinar series adds new dates and content for multi-specialty support. LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the extension of its digital learning webinar series "Advancing Dentistry" for remote dental training and …

BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAbout BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of ...700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg)

BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year.

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental ...

IRVINE, Calif., Jan. 20, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a continuation of their collaboration with BMW Performance Center West (BMW PCW) at The Thermal Club near Palm Springs, to offer dentists the unique opportunity to experience two state-of-the-art pieces of technology; the Waterlase dental laser and BMW award-winning ...Dental laser interface system and method · Patent number: 11568978 · Abstract: Embodiments of the invention provide a system of controlling a dental laser ...Dec 4, 2023 · Biolase Inc (NASDAQ:BIOL)’s Major holders. Investors are also buoyed by the number of investors in a company, with Biolase Inc having a total of N/A institutions that hold shares in the company. The top two institutional holders are Walleye Capital LLC with over 14205.0 shares worth more than $0.1 million. To access the call replay, dial 1-877-481-4010 or +1 919-882-2331 (International) and enter replay passcode: 48764. About BIOLASE BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in …View and filter SEC Filings by group or type. Annual Reports Quarterly Reports View All. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed ...

Filter stock price historical data by date with the ability to view Opens, Highs, Lows, Closes, VWAPs, Volume % Change, Change, Trade Value and Trades. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023.BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…LAKE FOREST, Calif., May 4, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 …LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable …

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2021 and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, ...

Nov 7, 2023 · BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of 14,000,000 shares of its common stock at a price to the public of $1.03 per share, less underwriting discounts and commissions.BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu...BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including …A company with a name that ends in “inc.” is incorporated, giving its owners, officers and investors specific legal advantages. Essentially, these key people in the business have no personal liability in the event that the business fails or...LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …Feb 2, 2021 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ...

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ...

IRVINE, Calif., June 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registered direct offering of approximately $6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to …

Feb 27, 2023 · LAKE FOREST, Calif., Feb. 27, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has ... May 26, 2023 · LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a ... BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year.BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the... Tracfone Wireless Inc is one of the leading wireless communication providers in the United States. With a wide range of affordable plans and extensive coverage, Tracfone has garnered a loyal customer base over the years.Innovative Technology Continues to be Recognized by Industry Peers. LAKE FOREST, Calif., July 17, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that its Epic Hygiene dental laser, the only hygiene dental laser cleared by the U.S. Food and Drug Administration (FDA) for laser bacterial …Feb 2, 2021 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ... View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ...BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions.LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Instagram:https://instagram. j.p. morgan personal advisorsbuyback program applecrypto com newsbest way to buy carnival stock BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… nvidia stock forumetfs that pay dividends monthly BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ... is guardian direct good dental insurance BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $26.00 , which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.